Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Risk factors for cognitive decline in children treated for brain tumors.

Duffner PK.

Eur J Paediatr Neurol. 2010 Mar;14(2):106-15. doi: 10.1016/j.ejpn.2009.10.005. Review.

PMID:
19931477
2.
3.

The therapy of infantile malignant brain tumors: current status?

Kalifa C, Grill J.

J Neurooncol. 2005 Dec;75(3):279-85. Review.

PMID:
16195802
4.

The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.

Cancer J Sci Am. 1998 Mar-Apr;4(2):110-24.

PMID:
9532413
5.

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.

Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M.

Strahlenther Onkol. 2003 Sep;179(9):585-97. Review.

PMID:
14628124
6.
7.

Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.

Grill J, Viguier D, Kieffer V, Bulteau C, Sainte-Rose C, Hartmann O, Kalifa C, Dellatolas G.

J Neurosurg. 2004 Nov;101(2 Suppl):152-8.

PMID:
15835102
8.

Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.

Macedoni-Luksic M, Jereb B, Todorovski L.

Pediatr Hematol Oncol. 2003 Mar;20(2):89-101.

PMID:
12554520
9.

Treatments for astrocytic tumors in children: current and emerging strategies.

Burzynski SR.

Paediatr Drugs. 2006;8(3):167-78. Review.

PMID:
16774296
10.

Long-term consequences of CNS treatment for childhood cancer, Part II: Clinical consequences.

Duffner PK, Cohen ME.

Pediatr Neurol. 1991 Jul-Aug;7(4):237-42. Review.

PMID:
1930413
11.

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM.

J Clin Oncol. 2001 Aug 1;19(15):3470-6.

PMID:
11481352
12.

Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.

Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA.

Pediatr Neurosurg. 1996 Oct;25(4):174-81.

PMID:
9293544
14.

Cognitive functions in survivors of primary central nervous system lymphoma.

Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE.

Neurology. 2004 Feb 24;62(4):548-55.

PMID:
14981169
15.

Medulloblastoma: clinical and biologic aspects.

Packer RJ, Cogen P, Vezina G, Rorke LB.

Neuro Oncol. 1999 Jul;1(3):232-50. Review.

16.

Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up.

Brière ME, Scott JG, McNall-Knapp RY, Adams RL.

Pediatr Blood Cancer. 2008 Feb;50(2):337-40.

PMID:
17458873
17.
18.

Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.

Iuvone L, Mariotti P, Colosimo C, Guzzetta F, Ruggiero A, Riccardi R.

Cancer. 2002 Dec 15;95(12):2562-70.

19.

Factors affecting intellectual outcome in pediatric brain tumor patients.

Ellenberg L, McComb JG, Siegel SE, Stowe S.

Neurosurgery. 1987 Nov;21(5):638-44.

PMID:
3696394
20.

Neuropsychological impact of treatment of brain tumors.

De Luca CR, Conroy R, McCarthy MC, Anderson VA, Ashley DM.

Cancer Treat Res. 2009;150:277-96. doi: 10.1007/b109924_17. Review. No abstract available.

PMID:
19834674
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk